Quick Answer
Sana Biotechnology, Inc. reported Total Assets of $416.89 million for fiscal year 2025.
Sana Biotechnology, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $416.89M | -16.8% |
| 2024 | $501.02M | -11.4% |
| 2023 | $565.30M | -31.3% |
| 2022 | $822.72M | -27.2% |
| 2021 | $1.13B | +54.7% |
| 2020 | $730.30M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $435.43M | -22.2% | +20.4% |
| June 30, 2025 | $361.64M | -41.5% | -18.8% |
| March 31, 2025 | $445.47M | -34.6% | -11.1% |
| December 31, 2024 | $501.02M | -11.4% | -10.4% |
| September 30, 2024 | $559.39M | -11.4% | -9.6% |
| June 30, 2024 | $618.67M | -12.5% | -9.2% |
| March 31, 2024 | $681.38M | -8.8% | +20.5% |
| December 31, 2023 | $565.30M | -31.3% | -10.5% |
- Sana Biotechnology, Inc. showed a decrease of -16.8% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Sana Biotechnology, Inc.’s total assets has declined by 42.9% (from $730.30 million to $416.89 million).
- The most recent figure is from Sana Biotechnology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: